Evaluation of a Dutch version of the AIMS2 for patients with rheumatoid arthritis.
about
Dutch translation and cross-cultural adaptation of the PROMISĀ® physical function item bank and cognitive pre-test in Dutch arthritis patients.Translation and validation study of the Persian version of the Arthritis Impact Measurement Scales 2 (AIMS2) in patients with osteoarthritis of the knee.Randomised controlled trial of local corticosteroid injections for de Quervain's tenosynovitis in general practice.Development of a questionnaire for identification of the risk factors for osteoarthritis of the knees in developing countries. A pilot study in Iran and Bangladesh. An ILAR-COPCORD phase III study.Reproducibility and responsiveness of the Symptom Severity Scale and the hand and finger function subscale of the Dutch arthritis impact measurement scales (Dutch-AIMS2-HFF) in primary care patients with wrist or hand problems.We should not forget the foot: relations between signs and symptoms, damage, and function in rheumatoid arthritisDo the Washington Panel recommendations hold for Europe: investigating the relation between quality of life versus work-status, absenteeism and presenteeism.Satisfactory cross cultural equivalence of the Dutch WOMAC in patients with hip osteoarthritis waiting for arthroplastySensitivity to change of AIMS2 and AIMS2-SF components in comparison to M-HAQ and VAS-pain.Changes in priorities for improvement in patients with rheumatoid arthritis during 1 year of anti-tumour necrosis factor treatment.Translation and validation of the Dutch version of the Effective Consumer Scale (EC-17).Measurement properties of rheumatoid arthritis-specific quality-of-life questionnaires: systematic review of the literature.Health care use of patients with osteoarthritis of the hip or knee after implementation of a stepped-care strategy: an observational study.Factors Associated With Referral to Secondary Care in Patients With Osteoarthritis of the Hip or Knee After Implementation of a Stepped-Care Strategy.The usage of functional wrist orthoses in patients with rheumatoid arthritis.Muscle characteristics in patients with chronic systemic inflammation.Development of the "Treatment beliefs in knee and hip OsteoArthritis (TOA)" questionnaire.Personal attributes as determinants of timely care in rheumatoid arthritis.Effects of a group-based exercise and educational program on physical performance and disease self-management in rheumatoid arthritis: a randomized controlled study.Coping in adult patients with severe haemophilia.The utility of the Dutch Arthritis Impact Measurement Scales 2 for assessing health status in individuals with haemophilia: a pilot study.Validity of health status measurement with the Dutch Arthritis Impact Measurement Scale 2 in individuals with severe haemophilia.Evaluation of the arthritis impact measurement scales (AIMS2) in Finnish patients with rheumatoid arthritis.Outcome in adults with juvenile idiopathic arthritis. Comparison of the DUTCH-AIMS2 between JIA and RA.Lost productivity in four European countries among patients with rheumatic disorders: are absenteeism and presenteeism transferable?Sexual functioning of people with rheumatoid arthritis: a multicenter study.Muscle mass, muscle strength, functional performance, and physical impairment in women with the hypermobility type of Ehlers-Danlos syndrome.What determines the possession of assistive devices among patients with rheumatic diseases? The influence of the country-related health care system.Preliminary effects of a regional approached multidisciplinary educational program on healthcare utilization in patients with hip or knee osteoarthritis: an observational study.
P2860
Q33454543-8434F5A8-D509-46AE-AB79-2217E1C6F180Q33489079-D7277351-0B6C-4D8C-8EA8-A2A519877475Q33513015-53F80AE6-3B35-4B11-9648-3B5626E22475Q33655507-02AA55C4-A224-45A2-9DE6-114B005BE738Q35165720-EC1DBE69-B44D-49F0-A69E-9CB352783295Q35463979-51D57F06-C8E8-4AA5-9899-8F7AE9EF56EFQ35518619-0E5D32B0-49A3-4960-AE41-A9CC78372E8BQ35553165-E413C7AF-F51F-4E4E-BA40-59961D4C1B51Q35553671-94D90B90-7F93-4560-BF1A-D9D796576311Q36204182-0F8C5F92-3C3A-48E6-ABA0-81E9E41D4B33Q36622065-17B713A7-9038-4231-BD5D-6340A7A6F938Q38213143-AFCD7A5F-3CEC-4465-8165-29FC6E36B465Q38247083-3AAFA578-D1F6-4354-805C-3B48B4ABD9A1Q38869688-DCFBA26E-20E7-4AA2-8E15-E7868CF5469CQ39330508-328F8578-D151-4F6F-A52D-27FBEECA9E17Q39584426-0A8AA444-CECC-4B6A-8E0D-6D1DC9440166Q41712011-A656880D-8A44-4BBC-8A06-87E51B11E565Q42955827-C90A91CF-69F8-408B-A251-E1AD753B0C06Q43761211-91444C39-DEC0-4964-8543-7657B74036E3Q45861747-FC6D5B74-07B5-4E5C-82C7-6AF913B054EBQ45873285-EE7AA246-0247-4CC3-B9EC-760B3CC23142Q45875842-02D689AF-FE9D-457A-85A7-855355FAB985Q47363475-383F8425-FF8B-4452-A384-772CE7BD989EQ47396290-F2B92D3A-267C-4D8F-8485-4BB319756DCAQ47659974-100E49D4-2BD1-4D33-9A91-4B7E05ECD861Q48455659-23C577AD-60FD-4D21-95DF-F84C7CC83937Q49025194-202DA145-95E9-47AC-AE20-7A280CEBC957Q51274522-DEC0074B-3502-4EC2-8927-7D97E3EFE06DQ55260410-7D3CBF29-7FF1-47ED-8EA4-0A856274E96F
P2860
Evaluation of a Dutch version of the AIMS2 for patients with rheumatoid arthritis.
description
1996 nĆ® lÅ«n-bĆ»n
@nan
1996幓ć®č«ę
@ja
1996幓å¦ęÆęē«
@wuu
1996幓å¦ęÆęē«
@zh-cn
1996幓å¦ęÆęē«
@zh-hans
1996幓å¦ęÆęē«
@zh-my
1996幓å¦ęÆęē«
@zh-sg
1996幓åøč”ęē«
@yue
1996幓åøč”ęē«
@zh
1996幓åøč”ęē«
@zh-hant
name
Evaluation of a Dutch version of the AIMS2 for patients with rheumatoid arthritis.
@en
Evaluation of a Dutch version of the AIMS2 for patients with rheumatoid arthritis.
@nl
type
label
Evaluation of a Dutch version of the AIMS2 for patients with rheumatoid arthritis.
@en
Evaluation of a Dutch version of the AIMS2 for patients with rheumatoid arthritis.
@nl
prefLabel
Evaluation of a Dutch version of the AIMS2 for patients with rheumatoid arthritis.
@en
Evaluation of a Dutch version of the AIMS2 for patients with rheumatoid arthritis.
@nl
P2093
P356
P1476
Evaluation of a Dutch version of the AIMS2 for patients with rheumatoid arthritis.
@en
P2093
P304
P356
10.1093/RHEUMATOLOGY/35.8.755
P577
1996-08-01T00:00:00Z